Shedding light on a novel circuit within primary motor cortex as a target for neuromodulation - Scorecard - MDSpire

Shedding light on a novel circuit within primary motor cortex as a target for neuromodulation

  • By

  • Caroline Tscherpel

  • Christian Grefkes

  • April 22, 2025

  • 0 min

Share

Clinical Scorecard: Exploring a New Circuit in the Primary Motor Cortex as a Potential Focus for Neuromodulation Therapy

At a Glance

CategoryDetail
ConditionMotor function impairment due to neurological diseases such as stroke and Parkinson’s disease
Key MechanismsIdentification of inter-effector regions within the primary motor cortex (M1) linked to the somato-cognitive action network, involving white matter connections (plis de passage) bridging motor and sensory cortices and connected to subcortical structures
Target PopulationPatients with motor impairments from brain lesions or neurodegenerative diseases
Care SettingNeurological and neurorehabilitation clinical settings utilizing neuromodulation therapies

Key Highlights

  • Discovery of three inter-effector regions within M1 that interrupt the classical homunculus and connect to cognitive and motor planning areas.
  • Plis de passage white matter structures anatomically link these inter-effector regions to the somato-cognitive action network.
  • Neuromodulation therapies targeting M1 may need to consider differential effects on effector-specific versus inter-effector areas for improved motor recovery.

Guideline-Based Recommendations

Diagnosis

  • Utilize functional neuroimaging and intraoperative electrical recordings to identify inter-effector regions within M1.
  • Consider resting-state fMRI connectivity analyses focusing on plis de passage coordinates to map the somato-cognitive action network.

Management

  • Apply non-invasive neuromodulation techniques (e.g., TMS, tDCS) targeting M1 with awareness of inter-effector and effector-specific regions.
  • Incorporate knowledge of somato-cognitive action network connectivity to optimize brain stimulation protocols for motor recovery.

Monitoring & Follow-up

  • Monitor motor evoked potentials (MEPs) elicited by stimulation of inter-effector regions to assess diffuse motor responses.
  • Track changes in functional connectivity within M1 and related subcortical structures during neuromodulation therapy.

Risks

  • Recognize interindividual variability in response to neuromodulation therapy post-stroke.
  • Acknowledge the current unknowns regarding how stimulation of inter-effector areas influences motor system reorganization.

Patient & Prescribing Data

Patients with motor impairments due to stroke or Parkinson’s disease undergoing neuromodulation therapy

Neuromodulation targeting M1 shows moderate efficacy with variability; understanding inter-effector regions may enhance therapeutic outcomes.

Clinical Best Practices

  • Integrate anatomical and functional mapping of M1 to distinguish effector-specific and inter-effector regions before neuromodulation.
  • Tailor brain stimulation protocols to engage the somato-cognitive action network for improved sensorimotor integration and motor planning.
  • Consider subcortical connectivity, especially with basal ganglia and thalamus, when designing neuromodulation strategies.
  • Use multimodal assessment (histology, neuroimaging, intraoperative recordings) to guide individualized therapy.

References

Original Source(s)

Related Content